See More From Your Mammogram — See the Heart Behind It.
Smarter Screening Starts Here.
Mammo with Heart uses an FDA-cleared AI screening tool to detect signs of breast arterial calcifications (BAC) during routine mammograms — offering valuable insights into heart health without any extra scans or appointments.
Why this matters:
- Leading Cause of Death: Cardiovascular disease (CVD) is the number one killer of women in the United States and worldwide.
- Prevalence: Approximately 44-45% of women in the U.S. are living with cardiovascular disease.
- Early Insight: The presence of arterial calcifications on a mammogram may provide valuable information about cardiovascular risk- insights that otherwise might go unnoticed until later in life.
Frequently Asked Questions
Mammo with Heart utilizes cmAngio®, an FDA-cleared artificial intelligence (AI) detection software, to determine the presence or absence of breast arterial calcification (BAC) as an incidental finding in standard-view screening mammograms. The cmAngio® software is not FDA-cleared for use with screening mammograms that require displacement or alternative views; therefore, Mammo with Heart is not available to patients who need alternative views for their screening. The detection of BAC indicates calcium buildup within the breast arterial wall. While BAC has been associated with an increased risk of coronary heart and cardiovascular disease, its presence or absence does not constitute a diagnosis and should not be used alone to determine cardiovascular risk. Results from Mammo with Heart may support further clinical evaluation or patient management at the discretion of a primary care physician, cardiologist, or other specialist. If BAC is detected, please consult your healthcare provider for additional information, assessment, or treatment options.
